Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-14-000948
Filing Date
2014-03-31
Accepted
2014-03-31 17:15:29
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT form10k.htm 10-K 1646030
2 GRAPHIC image_002.jpg GRAPHIC 10131
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 18588
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 18379
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 10117
  Complete submission text file 0001493152-14-000948.txt   6933882

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE trgm-20131231.xml EX-101.INS 786654
7 XBRL SCHEMA FILE trgm-20131231.xsd EX-101.SCH 64172
8 XBRL CALCULATION FILE trgm-20131231_cal.xml EX-101.CAL 82246
9 XBRL DEFINITION FILE trgm-20131231_def.xml EX-101.DEF 148141
10 XBRL LABEL FILE trgm-20131231_lab.xml EX-101.LAB 433578
11 XBRL PRESENTATION FILE trgm-20131231_pre.xml EX-101.PRE 305863
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-K | Act: 34 | File No.: 000-53071 | Film No.: 14731148
SIC: 2834 Pharmaceutical Preparations